Key result
Veno-arterial extracorporeal membrane oxygenation offers an overall survival to hospital discharge between 55% and 78% in patients suffering from myocarditis-induced cardiogenic shock.
Why the study?
Does veno-arterial extracorporeal membrane oxygenation (VA-ECMO) improve outcomes in adult patients with cardiogenic shock due to myocarditis?
Population
Adult patients with cardiogenic shock due to myocarditis refractory to optimal maximal medical treatment
Design
Review
Authors
Loading...
Review summarizes myocarditis spectrum; leaves open prospective validation of etiology-specific therapies.
Does veno-arterial extracorporeal membrane oxygenation (VA-ECMO) improve outcomes in adult patients with cardiogenic shock due to myocarditis?
This review summarizes the literature on the use of VA-ECMO as temporary mechanical circulatory support for adult patients with refractory cardiogenic shock due to myocarditis.
Pozzi et al. (2016) conducted a review in Cardiogenic shock due to myocarditis. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was evaluated on Survival to hospital discharge. Veno-arterial extracorporeal membrane oxygenation offers an overall survival to hospital discharge between 55% and 78% in patients suffering from myocarditis-induced cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: